Search results
I Thought an Arthritis Diagnosis Would End My Running Career. A Year Later, I Finished My First...
PopSugar· 6 days agoIn December 2016, when I was 28 years old, I was nearing the end of my training cycle for my first...
Noxopharm scales up production of lupus drug SOF-SKN™ to GLP standards
Proactive Investors· 7 hours agoNoxopharm Ltd (ASX:NOX, OTC:NOXOF) has reached a major drug development milestone in scaling up...
New Clinical Guidance for Sjögren-Related Neuropathy
Medscape· 6 days agoNew guidelines to manage peripheral neuropathy related to Sjogren disease have been developed by a multidisciplinary team of physicians from across...
Sternoclavicular joint pain: Symptoms, causes, and more
Medical News Today· 5 days agoPain in the sternoclavicular joint can result from inflammation, injury, or tissue degeneration. The...
AbbVie widens search for next hit drug with psychiatric deal worth up to $2B
Crain s Chicago Business· 13 hours agoAbbVie, which already has a growing psychiatry portfolio, is paying Gilgamesh $65 million upfront and as much as $1.95 billion in aggregate option fees and milestones in the future. Under the ...
Serum Metabolome Identifies Cancer in Rheumatic Disease
Medscape· 4 days agoA recent study revealed that alterations in the serum metabolome indicated the presence of...
Stelara interactions: Other medications, alcohol, and more
Medical News Today· 4 days agoStelara (ustekinumab) is a brand-name injectable drug prescribed for certain autoimmune conditions....
Chronic Pain Help At Rosedale Acupuncture & Wellness
KXAN via Yahoo News· 6 days agoDo you have long-term, chronic pain…maybe you feel older than you are? Dr. Lucas Brown, DAOM, LAc with Rosedale Acupuncture and Wellness spoke with...
EU researchers are taking fresh approaches to understanding immune-system disorders for more...
Medical Xpress· 4 days agoThe study is part of a research project examining links between immune-system illnesses and external...
Celltrion USA's adalimumab-aaty biosimilar to HUMIRA® now available at low wholesale acquisition...
Rome Sentinel· 4 days agoUSA under the brand name YUFLYMA®, which launched in July 2023 and is available at a 5% discount to the current WAC list price of HUMIRA. Adalimumab-aaty is approved for the treatment ...